As our first speaker we welcome Gulliver 2018 winner Keyn to the stage. This Leiden based startup is building an application that has found the sweet spot between security and ease-of-use.

General director Thijs will give us an insight into BioPartner's expansion plans, which have been developed due to the incubators' success in the Bio Science Park.

We study cell-fate decision-making using embryonic stem cells as a model system. Stem cells integrate a large number of cues to direct their development into a great variety of cell types. Using single-cell transcriptomics and single-molecule microscopy in combination with machine learning and mathematical modeling we seek to unravel the dynamics of the decision making process and understand the interplay of internal factors (epigenetics, cell cycle, stochastic gene expression) and external factors (signaling molecules, cell-cell contacts, mechanical cues). We believe that the basic principles discovered through our research will be of great value for applications in regenerative medicine and the eradication of cancer stem cells.